NEW YORK ( TheStreet) -- WuXi PharmaTech (Cayman (NYSE: WX) hit a new 52-week low Monday as it is currently trading at $10.84, below its previous 52-week low of $10.95 with 11,161 shares traded as of 9:56 a.m. ET. Average volume has been 277,600 shares over the past 30 days.

WuXi PharmaTech (Cayman has a market cap of $830 million and is part of the health care sector and drugs industry. Shares are down 31.2% year to date as of the close of trading on Friday.

Wuxi PharmaTech (Cayman) Inc., through its subsidiaries, operates as a pharmaceutical, biotechnology, and medical device research and development outsourcing company primarily in the People's Republic of China and the United States. The company has a P/E ratio of 8.7, below the average drugs industry P/E ratio of 9.1 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates WuXi PharmaTech (Cayman as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself. You can view the full WuXi PharmaTech (Cayman Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)

WuXi PharmaTech (WX) Showing Signs Of Being Strong And Under The Radar

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)

Strong And Under The Radar Today: WuXi PharmaTech (WX)

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)